Journal Article

DKFZ-2023-00478

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Chronic Active Epstein-Barr Virus Infection controlled by allogeneic stem cell transplantation and EBV-specific T-cells.

Meedt, E. ; Weber, D. ; Bonifacius, A. ; Eiz-Vesper, B. ; Maecker-Kolhoff, B. ; Delecluse, S.DKFZ* ; Delecluse, H.-J.DKFZ* ; Lorenz, M. ; Schwarz, K. ; Meedt, S. T. ; Braess, J. ; Herr, W. ; Holler, E. ; Edinger, M. ; Wolff, D.

2023
Oxford Journals Oxford

This record in other databases:  

Please use a persistent id in citations: doi:10.1093/cid/ciad131

Abstract: We report sustained remission of chronic active EBV infection in a 27-year-old female patient treated with third-party EBV-specific T-cells followed by allogeneic HSCT. The viremia cleared after administration of anti-T-lymphocyte globulin for GvHD prophylaxis. Subsequent expansion of EBV-infected host T-cells was controlled by transfusion of donor-derived EBV-specific T-cells.

Keyword(s): CAEBV ; EBV-specific T-cells ; allogeneic stem cell transplantation ; anti-T-lymphocyte globulin

Note: 2023 Jun 16;76(12):2200-2202

---

Contributing Institute(s):

1. F100 Pathologie infektionsbedingter Tumoren (F100)

Research Program(s):

1. 316 - Infektionen, Entzündung und Krebs (POF4-316) (POF4-316)

Appears in the scientific report 2023

---

Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 10 ; JCR ; National-Konsortium ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---